COMMUNIQUÉS West-GlobeNewswire

IMUNON to Present Phase 3 Ovarian Cancer Study of IMNN-001 at ESMO Congress
14/10/2025
Prestigious European Society for Medical Oncology Conference “trials-in-progress” session Pivotal OVATION 3 trial of its DNA-mediated immunotherapy in newly diagnosed patients underway Company on track with established [...]
Flare Therapeutics to Present FX-909 Phase 1A Data in Oral Presentation at Upcoming AACR-NCI-EORTC International Conference
14/10/2025
CAMBRIDGE, Mass., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Flare Therapeutics Inc. (FlareTx), a clinical-stage biotechnology company targeting transcription factors to discover precision medicines for oncology and other [...]
FibroBiologics to Present at the 2025 ThinkEquity Conference
14/10/2025
HOUSTON, Oct. 14, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of [...]
As "Uptober" Ignites Crypto Market, Bonk, Inc. Revs Up Its Revenue-Generating Engine
14/10/2025
Company to Capitalize on its Position as the Most Widely Held Token on Solana and a Historically Strong Q4 for Digital Assets SCOTTSDALE, AZ, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Bonk, Inc. (Nasdaq: BNKK) (the “Company”), [...]
Profound Medical to Participate in the Stifel 2025 Healthcare Conference
14/10/2025
TORONTO, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, AI-powered, [...]
Cellectar Biosciences Presented Promising Preclinical Data in Poster Presentation at the American Association for Cancer Research (AACR) Special Conference on Pancreatic Cancer Research
14/10/2025
CLR 225 (225Ac-phospholipid ether) Demonstrates Meaningful Inhibition of Tumor Growth and Potential Survival Benefit In Three Pancreatic Cancer Xenograft Models FLORHAM PARK, N.J., Oct. 14, 2025 (GLOBE NEWSWIRE) -- [...]
Microbot Medical® Secures U.S. Based Logistics Partner to Support the Commercialization of Its LIBERTY® Endovascular Robotic System
14/10/2025
The Experienced MedTech Logistics Provider Will Help Ensure Effective and Efficient Inventory Management and Customer Support The Company is on Track to Commence the Launch of LIBERTY ® during Q4 This Year HINGHAM, Mass [...]
LB Pharmaceuticals Appoints James Rawls, Pharm.D., as Senior Vice President of Regulatory Affairs
14/10/2025
NEW YORK, Oct. 14, 2025 (GLOBE NEWSWIRE) -- LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX) today announced the appointment of James Rawls, Pharm.D., as Senior Vice President of Regulatory [...]
Counterpart Health Expands Proven Flywheel for HEDIS Excellence to Third-Party Partners
14/10/2025
Technology platform again powers top-tier HEDIS results for Clover Health Medicare Advantage plans SAN FRANCISCO, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Counterpart Health, Inc. (“Counterpart”), a wholly owned subsidiary of [...]
Aligos Therapeutics to Present at the H.C. Wainwright Liver Disease Conference
14/10/2025
SOUTH SAN FRANCISCO, Calif., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies [...]
Vireo Growth Inc. Announces Closing of Acquisition of Outstanding Senior Secured Convertible Notes of Schwazze
14/10/2025
– Parties enter into Restructuring Support Agreement; Vireo to bid to acquire control of Schwazze assets – – Schwazze operates 63 dispensaries and 10 manufacturing facilities in Colorado and New Mexico – MINNEAPOLIS, [...]
Celularity Announces Peer-Reviewed Publication of Phase 2 Clinical Trial Results Demonstrating the Safety and Efficacy of Human Placenta-Derived Cells (PDA-002) for Diabetic Foot Ulcers Complicated by Peripheral Artery Disease
14/10/2025
First-in-class regenerative therapy for diabetic foot ulcers complicated by peripheral artery disease Celularity PDA-002 achieved durable wound healing with just two intramuscular doses As a qualified stem cell therapy [...]
Immix Biopharma to Present at the Guggenheim 2nd Annual Healthcare Innovation Conference
14/10/2025
LOS ANGELES, CA, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (“ImmixBio”, “Company”, “We” or “Us” or ”IMMX”), the global leader in relapsed/refractory AL Amyloidosis, today announced that it will present and [...]
ZymoChem Named Startup of the Year by The International Textile Manufacturers Federation
14/10/2025
SAN LEANDRO, Calif., Oct. 14, 2025 (GLOBE NEWSWIRE) -- ZymoChem , the materials company decarbonizing the chemical industry through biological manufacturing, announces its recognition as a Startup of the Year by The [...]
Imprivata Acquires Verosint to Add AI-Powered Risk Signaling to its Leading Enterprise Access Management Platform
14/10/2025
Integration of Verosint Identity Threat Detection & Response with Imprivata Enterprise Access Management will strengthen the company’s advanced and passwordless access strategy to bolster security, improve workflow [...]
Rendever Leads Expansion of Virtual Reality in Hospice Care
14/10/2025
The AgeTech company expands hospice partnerships to enhance end-of-life care with immersive experiences for patients and families BOSTON, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Rendever , the company leading the industry in [...]
Bicycle Health Grows Leadership Team to Further Expand Access to Opioid Use Disorder Care for Patients in the Criminal Justice System
14/10/2025
Steve Tomlin has decades of experience bringing opioid and substance use disorder care to criminal justice populations BOSTON, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Bicycle Health , the nation’s largest provider of virtual [...]
HIV Self-Testing Just Got Faster: FDA Approves the 1-Minute INSTI® HIV Self Test
14/10/2025
The fastest, at-home HIV test is now available in the U.S., expanding access to rapid, private, and convenient self-testing A Major Step Forward in HIV Prevention The INSTI ® HIV Self Test delivers highly accurate [...]
Dewpoint Therapeutics Announces Presentation at AACR-NCI-EORTC 2025
14/10/2025
Dewpoint will present one poster at AACR-NCI-EORTC MYC is a highly desirable oncogenic target that historically eluded drug hunters Small molecules that inhibit the oncogenic function of MYC were discovered using [...]

Pages